Onconova Therapeutics stock was absolutely crushed to start out the week after the company reported results from its late-stage cancer study.
The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp and Yum China.
The quest for upside and value often leads to stocks with low market caps or stocks with low share prices — frequently stocks that are trading under $10.
Onconova Therapeutics led the bulls early in Tuesday’s trading session on positive data from an ongoing Phase 1/2 clinical trial.
Keep in mind that the volatility of this past week created a rift. Analyst calls made on Monday might have been dealing with ancient history in share prices by the time Wednesday, Thursday or Friday...
Friday's top analyst upgrades, downgrades and initiations include Abercrombie & Fitch, Akamai Technologies, Citigroup, Pollo Loco, Netflix and Salesforce.com.
Onconova Therapeutics has announced the submission of an investigational new drug application to the FDA.
Wednesday's top analyst upgrades, downgrades and initiations include Brinker International, Cypress Semiconductor, Starbucks and Windstream.
Among speculative small-cap biotechs, analyst calls are often accompanied with upside price targets of 50%, 100% or even 200%. This is because the companies are often all-in bets on one or two...
Tuesday's top analyst upgrades, downgrades and initiations include Alcatel-Lucent, AOL, Cisco Systems, EMC, Netflix and Tesla Motors.